Moores Cancer Center
April 21, 2011
Welcome and Overview
David Brenner, M.D., Dean, UCSD School of MedicineApril 21, 2011
Speakers: David Brenner
Run Time: 03 minutes
David Brenner, M.D., a distinguished physician-scientist, is Vice Chancellor for Health Sciences and Dean of the School of Medicine at the University...
Primary Animal Models for Combination Therapy: The HALT Program
Dennis Carson, M.D., Moores Cancer CenterApril 21, 2011
Speakers: Dennis Carson
Run Time: 12 minutes
Dennis Carson, M.D. is Director of the Rebecca and John Moores UCSD Cancer Center and Professor of Medicine at UCSD School of Medicine. He is also...
Targeting the PI3K/mTOR Pathway in Cancer
Christian Rommel, Ph.D., IntellikineApril 21, 2011
Speakers: Christian Rommel
Run Time: 34 minutes
Christian Rommel serves as Intellikine's Chief Scientific Officer. Dr. Rommel is responsible for the company's research, drug discovery and...
PI3Kγ, a Convergent Molecular Target for the Suppression of Tumor Inflammation, Growth and Progression
Judith Varner, Ph.D., Moores Cancer CenterApril 21, 2011
Speakers: Judith Varner
Run Time: 20 minutes
The Varner Lab studies the molecular mechanisms by which the tumor microenvironment promotes tumor growth and metastasis. Our most recent focus is on...
Keynote: Accelerating Drug Development and Biomarker Discovery: The I-SPY Trials
Laura Esserman, M.D., M.B.A., Carol Franc Buck Breast Care Center, UCSF Helen Diller Family Comprehensive Cancer CenterApril 21, 2011
Speakers: Laura Esserman
Run Time: 42 minutes
Dr. Laura Esserman, MD, MBA, is a Professor of Surgery and Radiology at UCSF and is the Director of the Carol Franc Buck Breast Care Center, an...
Unraveling Cancer Stem Cell Survival Mechanisms
Catriona Jamieson, M.D., Ph.D. and Kelly Frazer, Ph.D., Moores Cancer CenterApril 21, 2011
Speakers: Catriona Jamieson, Kelly Frazer
Run Time: 35 minutes
Catriona Jamieson, M.D., Ph.D. is Assistant Professor of Medicine in the Division of Hematology-Oncology and Director for Stem Cell Research at...
Control of Tumor Progression and Metastasis by Lymphocyte-Produced Cytokines
Michael Karin, Ph.D., UCSD School of MedicineApril 21, 2011
Speakers: Michael Karin
Run Time: 30 minutes
Dr. Karin made seminal contributions to the discipline of signal transduction describing how extracellular stimuli, including growth factors,...
Targeting Raf by Allosteric Inhibition Offers New Therapeutic Opportunities in Oncology
David Cheresh, Ph.D., Moores Cancer CenterApril 21, 2011
Speakers: David Cheresh
Run Time: 20 minutes
David Cheresh studies the mechanism of action of signaling networks that regulate cancer growth and metastasis and focuses on new strategies for...